Literature DB >> 28713669

The promise of emerging developments and concepts in mesothelioma.

Chuong D Hoang1.   

Abstract

Entities:  

Year:  2017        PMID： 28713669      PMCID： PMC5504109          DOI： 10.21037/tlcr.2017.06.05

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  6 in total

Review 1.  Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma.

Authors:  David J Sugarbaker
Journal:  J Thorac Oncol       Date:  2006-02       Impact factor: 15.609

2.  Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.

Authors:  Gérard Zalcman; Julien Mazieres; Jacques Margery; Laurent Greillier; Clarisse Audigier-Valette; Denis Moro-Sibilot; Olivier Molinier; Romain Corre; Isabelle Monnet; Valérie Gounant; Frédéric Rivière; Henri Janicot; Radj Gervais; Chrystèle Locher; Bernard Milleron; Quan Tran; Marie-Paule Lebitasy; Franck Morin; Christian Creveuil; Jean-Jacques Parienti; Arnaud Scherpereel
Journal:  Lancet       Date:  2015-12-21       Impact factor: 79.321

3.  Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy.

Authors:  Hasan Fevzi Batirel; Muzaffer Metintas; Hale Basak Caglar; Guntulu Ak; Perran Fulden Yumuk; Bedrettin Yildizeli; Mustafa Yuksel
Journal:  J Thorac Cardiovasc Surg       Date:  2015-10-09       Impact factor: 5.209

4.  Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

Authors:  Nicholas J Vogelzang; James J Rusthoven; James Symanowski; Claude Denham; E Kaukel; Pierre Ruffie; Ulrich Gatzemeier; Michael Boyer; Salih Emri; Christian Manegold; Clet Niyikiza; Paolo Paoletti
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

Review 5.  New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas.

Authors:  Brooke T Mossman; Arti Shukla; Nicholas H Heintz; Claire F Verschraegen; Anish Thomas; Raffit Hassan
Journal:  Am J Pathol       Date:  2013-02-08       Impact factor: 4.307

6.  Malignant pleural mesothelioma: an epidemiological perspective.

Authors:  Benjamin M Robinson
Journal:  Ann Cardiothorac Surg       Date:  2012-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.